Trial Profile
Phase II Study of Adjuvant Chemotherapy Consisting of S-1 Plus Oxaliplatin in Patients with Resected Stage III Gastric Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- Sponsors Yakult Honsha
- 06 Jun 2016 New trial record